Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Federal Jury in Dallas Finds Bard's IVC Blood Clot Filter Defective and Dangerous
By: PR Newswire Association LLC. - 23 Jul 2021Back to overview list

DALLAS, July 23, 2021 /PRNewswire/ -- For the fourth time since May, jurors in federal court have found that C.R. Bard's IVC blood clot filter is defective and responsible for injuries and complications. The latest verdict for trial lawyers at Dallas-based Martin Baughman brings combined monetary awards to more than $7 million.

"Four juries have now?sent a crystal-clear message?to Bard about?these defective products," said?Ben Martin,?Martin Baughman?trial lawyer.?"We will continue?trying these cases until Bard?takes responsibility."?

Martin Baughman represents several hundred individuals who have suffered injuries and complications caused by Bard's line of?IVC filters,?which include the Recovery, G2, G2X, Eclipse, Meridian?and?Denali.?The filters?are inserted into?a major vein, the?inferior vena cava?(IVC),?to prevent blood clots from moving to the heart?and lungs.?? ?

The spider-shaped devices are known to tilt, perforate vein walls, and fracture, causing metal pieces to dislodge and migrate into internal organs and other structures in the body. In addition, there is no evidence that they are effective at preventing pulmonary emboli. Although the filters are marketed as being removable, testimony in trial underscored that removal is difficult or impossible, especially after breakage.  ?

At one time, Bard, a subsidiary of Becton, Dickinson and Company (NYSE: BDX), faced more than 8,000 similar lawsuits that were consolidated in multidistrict litigation in?Phoenix. Martin Baughman and the firm's clients rejected a proposed settlement?that was inadequate.?Instead, the firm is moving forward with an aggressive schedule of individual trials across the U.S.?? ?

In the Dallas case, jurors found that Bard's Recovery IVC filter caused serious medical complications when it fractured after being implanted. The verdict includes $386,250 in damages.

"Once again, jurors have heard the facts and agreed that these filters are dangerous," said trial lawyer?Laura Baughman. "After recklessly marketing these products and placing profit over safety, it's time for Bard to acknowledge?how risky they are."?

"We are very happy the jury held Bard accountable for Bard's misdeeds," said Charla Aldous of Aldous\Walker, Dallas, Texas, who tried the case with Mr. Martin in Dallas.

The case is Debra Branch v. C.R. Bard Inc.et al., case No. 3:19-cv-02130. The trial team included?Mr. Martin, Ms. Aldous, Joshua Michaels and Emily Acosta of Martin Baughman, and Caleb Miller of Aldous\Walker.?

Martin?Baughman?attorneys have helped thousands of victims of accidents and injuries caused by catastrophic vehicular and trucking accidents, oil field explosions, medical and hospital negligence, medical device and pharmaceutical design defects, and personal injuries caused by negligence and gross negligence.??

Media?Contact:?

Robert Tharp?

214-420-6011?

Robert@androvett.com

Cision View original content:https://www.prnewswire.com/news-releases/federal-jury-in-dallas-finds-bards-ivc-blood-clot-filter-defective-and-dangerous-301340316.html

SOURCE Martin Baughman

Related companies:BD
Copyright 2021 PR Newswire Association LLC. Back to overview list
to the top ↑